Nicorette Microtab (Nicotine Betadex)

Nicotine, the active ingredient in Nicorette Microtab, is a nicotine replacement therapy presented as a sublingual tablet for sublingual use. It is intended to help adult smokers reduce dependence on tobacco and manage withdrawal symptoms during quitting attempts.

GNH USA supplies Nicorette Microtab as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics, comprehensive documentation, and responsive technical support throughout the procurement process.

Nicorette Microtab, a nicotine replacement therapy, is used to address nicotine dependence and related withdrawal. - Smoking cessation: assists adult smokers in quitting by providing controlled nicotine delivery. - Nicotine withdrawal management: reduces cravings and withdrawal symptoms during the quitting process. - Relapse prevention: supports maintaining abstinence after initial cessation.

Nicorette Microtab may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Mouth irritation: mild soreness or tingling under the tongue. - Nausea: feeling of queasiness after administration. - Headache: mild to moderate head discomfort. - Dizziness: transient light‑headed sensation.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Chest pain: unexpected thoracic discomfort that may indicate cardiac involvement. - Severe hypotension: marked drop in blood pressure leading to faintness.

Before using Nicorette Microtab, consider the following precautions to ensure safe and effective therapy. - Assess nicotine dependence: evaluate smoking history and level of dependence prior to initiation. - Medical supervision: use under guidance of a healthcare professional, especially for cardiovascular disease. - Avoid concurrent nicotine products: do not combine with other nicotine replacement therapies or tobacco to prevent overdose. - Not for non‑smokers: the product is intended only for individuals who are regular tobacco users seeking cessation. - Keep out of reach of children: store securely to prevent accidental ingestion. - Store at ambient temperature: keep in the original packaging, protect from moisture and excessive heat.

Nicotine can interact with other medicines, requiring attention to potential additive or metabolic effects.

Major Interactions (Avoid): - Concurrent use of multiple nicotine replacement products: risk of nicotine toxicity and related symptoms. - Use with illicit nicotine sources (e.g., e‑cigarettes): may lead to excessive nicotine exposure.

Moderate Interactions (Monitor Closely): - CYP1A2 substrate drugs (e.g., theophylline, clozapine): nicotine may increase their metabolism, reducing efficacy. - Beta‑adrenergic antagonists: nicotine‑induced tachycardia may be blunted, requiring monitoring. - MAO‑inhibitor antidepressants: combined use may increase risk of hypertension; observe blood pressure.